why choose us

Clinical Trials Search

Showing 17,590 of 132,963 result(s)
Large De-NOVo Coronary artEry Disease Treated With Sirolimus Drug Eluting Balloon (LOVE DEB)

Status: COMPLETED

Condition: Coronary Artery Disease

Interventions:

Date: 2022-12-06

IDUS in CBD Stone Recurrence High Risk Patients

Status: COMPLETED

Condition: Choledocholithiasis

Interventions: for patients with high risks of bile duct stones recurrence using IDUS during ERCP

Date: 2022-12-06

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Status: COMPLETED

Condition: Pulmonary Hypertension

Interventions: Oral inhalation using a capsule-based dry powder inhaler device.

Date: 2022-12-06

Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation

Status: Completed

Condition: Head and Neck Cancer

Interventions: A nerve stimulator device will be used in this study as a research tool to investigate whether a future (currently nonexistent) medical device might b

Date: 2022-12-06

Vamikibart in Participants With Uveitic Macular Edema

Status: Completed

Condition: Uveitic Macular Edema

Interventions: Participants will receive vamikibart IVT injection

Date: 2022-12-06

At-home Walking Cadence Functional Assessment and Recovery Trajectory for Older Adults Undergoing Major Surgery

Status: Completed

Condition: Gait, Unsteady

Interventions: Patients who are scheduled to have surgery at University of Chicago Medical Center (UCMC) who agree to use the step test application and study acceler

Date: 2022-12-06

Fiber Supplementation After Bariatric Surgery

Status: Completed

Condition: Bariatric Surgery Candidate

Interventions: Participants will consume 24 grams (days 1-15) and 48 grams (days 16-30) of potato starch.
Potato starch is a type 2 resistant starch that is ava

Date: 2022-12-06

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)

Status: Completed

Condition: Pulmonary Arterial Hypertension

Interventions: Administered by oral inhalation, using a Plastiape capsule-based dry powder inhaler.

Date: 2022-12-06

Stereotactic Ablative Radiation Therapy for Prostate Cancer

Status: Completed

Condition: Prostate Cancer

Interventions: SUPR-SABR prescription dose to the PTV_4000 will be 8 Gy per fraction for five fractions.
The prescription dose to PTV_3625 will be a minimum of

Date: 2022-12-06

PET;CT Characterization of Treatment Resistance

Status: Completed

Condition: Prostate Cancer

Interventions: Imaging scan

Date: 2022-12-06